Gsk Book Value Per Share Growth & History (GSK)
Gsk's book value per share was £3.79 for fiscal 2025.
View full Gsk company overviewGsk annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | £3.79 | £0.63 | +19.76% |
| 2024 | 2024-12-31 | £3.17 | £0.07 | +2.38% |
| 2023 | 2023-12-31 | £3.10 | £0.64 | +25.92% |
| 2022 | 2022-12-31 | £2.46 | -£0.34 | −12.04% |
| 2021 | 2021-12-31 | £2.79 | £0.09 | +3.17% |
| 2020 | 2020-12-31 | £2.71 | £0.59 | +27.85% |
| 2019 | 2019-12-31 | £2.12 | £1.42 | +201.41% |
| 2018 | 2018-12-31 | £0.70 | £0.72 | — |
| 2017 | 2017-12-31 | -£0.01 | -£0.24 | — |
| 2016 | 2016-12-31 | £0.23 | -£1.61 | −87.42% |
| 2015 | 2015-12-31 | £1.84 | — | — |
Gsk quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | £4.40 | £0.75 | +20.47% |
| Q1 2026 | 2026-03-31 | £4.44 | — | — |
| Q4 2025 | 2025-12-31 | £3.79 | £0.63 | +19.76% |
| Q3 2025 | 2025-09-30 | £4.01 | — | — |
| Q2 2025 | 2025-06-30 | £3.66 | — | — |
| Q4 2024 | 2024-12-31 | £3.17 | £0.07 | +2.38% |
| Q4 2023 | 2023-12-31 | £3.10 | £0.64 | +25.92% |
| Q4 2022 | 2022-12-31 | £2.46 | -£0.34 | −12.04% |
| Q4 2021 | 2021-12-31 | £2.79 | £0.09 | +3.17% |
| Q4 2020 | 2020-12-31 | £2.71 | £0.59 | +27.85% |
| Q4 2019 | 2019-12-31 | £2.12 | £1.42 | +201.41% |
| Q4 2018 · Dec 31 | 2018-12-31 | £0.70 | £0.72 | — |
| Q4 2017 · Dec 31 | 2017-12-31 | -£0.01 | — | — |
Gsk book value per share trends
Over the last five fiscal years, Gsk's book value per share increased from £2.71 to £3.79, a change of £1.09. The latest reported quarter, Q2 2026, shows £4.40.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Gsk source filings ↗